Sexually Transmitted Diseases Diagnostics Market Outlook (2022 to 2032)
[300 Pages Report] The sexually transmitted diseases diagnostics market is anticipated to record a CAGR of 7.9% during the forecast period (2022 to 2032).
The sexually transmitted diseases diagnostics market is expected to be valued at US$ 3.8 Billion in 2022 and is likely to reach US$ 6.4 Billion by 2032.
The rise in government bodies' initiatives is a key factor that is driving the sexually transmitted diseases diagnostics market growth.
In the last decade, the prevalence and incidence of STDs have increased dramatically. With the rise in frequency, countries around the world are focused on implementing nationwide screening programs to boost the adoption of sexually transmitted disease diagnostics coverage. Furthermore, reimbursement policies for sexually transmitted diseases diagnostics services have been beneficial.
These reasons are contributing considerably to the worldwide sexually transmitted diseases diagnostics market's expansion.
The advancement of technologies, awareness regarding the infection, availability of better treatment, and many other factors are growing the demand for sexually transmitted diseases diagnostics.
Customize your report by selecting specific countries or regions and save 30%!
What Changes has COVID-19 Brought About in the Sexually Transmitted Diseases Diagnostics Market?
The COVID-19 crisis has harmed the sexually transmitted diseases diagnostics market share. The sales of sexually transmitted disease diagnostics kits are likely to decline due to disruptions to healthcare services and other STD test services.
As per the sexually transmitted diseases diagnostics market analysis, the demand for sexually transmitted diseases diagnostics testing is likely to reduce in the aftermath of the pandemic by 40%. During the lockdown, the number of testing devices available in the market has reduced significantly, thus changing the Sexually transmitted diseases diagnostics market outlook.
Demand for sexually transmitted disease diagnostics has decreased due to the lack of awareness about the check-ups of the people who suffer from these infections and others who unwittingly spread the infection without any testing, especially in developing and underdeveloped countries.
The lack of resources and critical care services in the sexually transmitted diseases diagnostics market segments has collapsed the sales of sexually transmitted diseases diagnostics kits.
In countries such as the US, the sexually transmitted diseases diagnostics market shareis rising owing to the prevalence of STDs in teenagers despite the influence of the pandemic.
What are the Key Sexually Transmitted Diseases Diagnostics Market Dynamics?
Demand for sexually transmitted disease diagnostics is likely to rise as the awareness regarding STD diseases rises among people towards the infection, boosting the Sexually transmitted diseases diagnostics market share during the forecast period.
The sexually transmitted diseases diagnostics market share is being driven by a significant rise in patient check-ups, campaigns, government initiatives, and growing awareness related to the infection and others.
Over the last decade, the sexually transmitted diseases diagnostics market share has been rising all around the globe. The advancements in Sexually transmitted diseases diagnostics devices are performing a key role in changing the market outlook.
Other important reasons driving the growth of the sexually transmitted diseases diagnostics market are increased public awareness and patient education. Furthermore, the demand for sexually transmitted diseases diagnostics is expected to develop due to an increase in the global prevalence of STDs, increased patient awareness through education programs, and an increase in government initiatives.
The sexually transmitted diseases diagnostics market share is expected to grow high in the coming forecast period 2022 to 2032. The advanced level of diagnostic devices and betterment in the treatment plans are expected to lead to a growth in the demand for Sexually transmitted diseases diagnostics products.
Find your sweet spots for generating winning opportunities in this market.
Comparative View of Adjacent Sexually Transmitted Diseases Diagnostics Market
Sexually transmitted diseases diagnostics Market:
Attributes
Sexually transmitted diseases diagnostics Market
CAGR (2022 to 2032)
7.9%
Market Value (2026)
US$ 6.4 Billion
Growth Factor
Increased public awareness and patient education to drive the STD market growth.
Opportunity
Countries around the world are focused on implementing nationwide screening tests to boost the adoption of STD diagnostics.
Key Trends
The change from conventional methods to molecular diagnostics for the detection of STDs is driving the STD diagnostics market share.
HIV Diagnostics Market:
Attributes
HIV Diagnostics Market
CAGR (2022 to 2032)
7.9%
Market Value (2026)
US$ 4.07 Billion
Growth Factor
The rising global prevalence of HIV/AIDS, as well as the rising number of blood transfusions and blood donations.
Opportunity
Due to multiple advantages, the demand for technologically advanced PoC kits and instruments is on the rise
Key Trends
Key players' substantial investment in Research and Development efforts for the development of improved quality HIV testing kits for home use.
Point of Care Testing Market:
Attributes
Point of Care Testing Market
CAGR (2022 to 2032)
7.4%
Market Value (2026)
US$ 44.51 Billion
Growth Factor
POCT services have grown in popularity as the prevalence of chronic diseases and acute infections has increased around the world.
Opportunity
The demand for point-of-care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size.
Key Trends
POCT compliance, safety, and usability have become increasingly important as the scope of use and penetration in developing economies has grown.
STD diagnostics market growth is expected to be driven by an increase in patient awareness, such as education programs and expanding government efforts. Furthermore, the growing number of people who have several casual sex partners is supporting the rise in demand for sexually transmitted disease diagnostics.
The sexually transmitted diseases diagnostics market is expected to rise significantly over the projected period, owing to an increase in the number of technologically improved diagnostics tools that provide more precise testing findings.
A major transition from traditional laboratory testing to rapid point-of-care testing has been noted, which is fueling the sales of sexually transmitted diseases diagnostics with a technologically sophisticated product range that includes diagnostic kits, tools, and reagents.
What is the Segment Outlook for the Sexually Transmitted Diseases Diagnostics Market?
The STD diagnostics market is segmented based on disease type, location of testing, and region.
By disease type, the market is categorized into chlamydia, gonorrhoea, herpes simplex virus, syphilis, human papillomavirus (HPV), and other diseases (human immunodeficiency virus (HIV), chancroid, trichomoniasis, and hepatitis B). By location of testing, the STD diagnostics market is bifurcated into laboratory testing and point of care (POC) testing.
The laboratory testing segment of the STD diagnostics market accounted for the bulk of market share in the global sexually transmitted diseases diagnostics market in 2020 and is likely to remain dominant during the forecast period. Additionally, most of the diagnostic testing cases are performed in labs, which is expected to fuel the demand for STD diagnostics even more.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Which Segment is Anticipated to Dominate the Sexually Transmitted Diseases Diagnostics Market by Product?
Diagnostic laboratories are expected to dominate the Sexually transmitted diseases diagnostics market share with a CAGR of 7.2% in the forecast period 2022 to 2032. Due to continuous increases in technology and an increase in the number of tests in the laboratory, the demand for STD diagnostics is likely to expand in this segment.
The diagnostics laboratories are anticipated to rise in the Sexually transmitted diseases diagnostics market share in the forecast period 2022 to 2032.
Another segment that is experiencing a high rise in adoption is the point of care which is further expected to boost the demand for sexually transmitted diseases diagnostics testing. The changing market outlook and Sexually transmitted diseases diagnostics market trends are likely to positively impact the Sexually transmitted diseases diagnostics market share in the forthcoming years.
What is the Regional Analysis for the Sexually Transmitted Diseases Diagnostics Market?
Regions
CAGR
USA Market
7.7%
UK Market
6.7%
China Market
7.2%
Japan Market
6.3%
South Korea Market
5.7%
The North American region is anticipated to dominate in the sexually transmitted diseases diagnostics market share due to the increase in demand for sexually transmitted diseases diagnostics tests. In the region, the USA is expected to boost the regional demand for Sexually transmitted diseases diagnostics. The USA captured a CAGR of 7.7% in the Sexually transmitted diseases diagnostics market share in the forecast period 2022 to 2032.
In the US, chlamydia type of STD infection is likely to rise as it is the most commonly found infection in the country. Teenage girls between 15-25-year-old young girls found infected by this disease lift the growth of sexually transmitted diseases diagnostics market share in the forecast period.
Around 1.8 million cases founded in the US in 2019, as per the report. The regional STD diagnostics market trends in the US are expected to drive the demand for STD diagnostics in the North American region.
Asia is expected as the second dominating region in the STD diagnostics market share. China has a vast number of STD diagnostics tests in the region which is expected to boost the demand in the region during the forecast period. A CAGR of 7.2% is likely to be captured in the STD diagnostics market by the China market during the forecast period 2022 to 2032.
Other regions such as the UK, Japan, and South Korea are expected to have a lowerdemand for STD diagnostics as compared to North America and the US market in the forecast period. The STD diagnostics market outlook in this region is mainly due to a lack of knowledge and delays in the test and treatment are leading to a fall in the STD diagnostics market share.
How Strong is the Competition in the Sexually Transmitted Diseases Diagnostics Market?
Key manufacturing companies are anticipated to boost the Sexually transmitted diseases diagnostics market share in the coming forecast period 2022 to 2032.
These companies are collaborating and entering into partnerships and joint ventures with other industries to increase the growth of the sexually transmitted diseases diagnostics market share. The Food and Drug Administration of the US has cleared the CT/NG test to detect the infection, which is further boosting the Sexually transmitted diseases diagnostics market.
The sales of sexually transmitted diseases diagnostics testing products are likely to increase as demand is rising all around the globe.
Some recent developments in the sexually transmitted diseases diagnostics market include:
NASTAD (National Alliance of State and Territorial AIDS Directors) teamed with Building Healthy Online Communities in March 2021 to launch TakeMeHome, a free HIV and STD test kit home delivery initiative.
Ash, a sexual health firm, debuted STI at-home testing kits in September 2020. The exam consists of an online questionnaire that the respondent must complete before receiving personalized diagnostics.
What is the Growth Outlook for the Sexually Transmitted Diseases Diagnostics Market?
The sexually transmitted diseases diagnostics market is projected to register a CAGR of 7.9% during the forecast period (2022 to 2032).
Which is the Leading Region in the Sexually Transmitted Diseases Diagnostics Market?
During the forecast period, the USA is expected to lead the sexually transmitted diseases diagnostics market with a CAGR of 7.7% through 2032.
Which Segment Leads the Sexually Transmitted Diseases Diagnostics Market by Product?
Laboratories are expected to dominate the sexually transmitted diseases diagnostics market during the forecast period with a CAGR of 7.2% by the end of 2032.
What is the Projected Sexually Transmitted Diseases Diagnostics Market Size by 2032?
The sexually transmitted diseases diagnostics market is poised to be worth US$ 6.4 Billion by 2032.
Which was the Historical Size of the Sexually transmitted diseases diagnostics Market?
The sexually transmitted diseases diagnostics market size was valued at US$ 2.8 Billion in 2021.
Table of Content
1. Executive Summary | Sexually Transmitted Diseases Diagnostics Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Sexually Transmitted Diseases Diagnostics
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in Optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2015 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Disease
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Disease, 2015 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Disease, 2022 to 2032
8.3.1. Chlamydia
8.3.2. Gonorrhea
8.3.3. Syphilis
8.3.4. Genital Herpes
8.3.5. Hepatitis B
8.3.6. HIV/AIDS
8.3.7. Human Papillomavirus(HPV)
8.3.8. Others
8.4. Market Attractiveness Analysis By Disease
9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Diagnostic Test
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Diagnostic Test, 2015 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Diagnostic Test, 2022 to 2032
9.3.1. Culture/Isolation Of Organisms
9.3.2. Molecular Test
9.3.3. Immunology Assay
9.3.4. Other Type of Testing
9.4. Market Attractiveness Analysis By Diagnostic Test
10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Location Of Diagnostic Test
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Location Of Diagnostic Test, 2015 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Location Of Diagnostic Test, 2022 to 2032
10.3.1. Laboratory Testing
10.3.2. Point Of Care (PoC) Testing
10.4. Market Attractiveness Analysis By Location Of Diagnostic Test
11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Devices
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Devices, 2015 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Devices, 2022 to 2032
11.3.1. Laboratory Devices
11.3.1.1. Thermal Cyclers-PCR
11.3.1.2. Lateral Flow Readers Immunochromatographic Assays Flow Cytometers
11.3.1.3. Absorbance Microplate Reader Enzyme-Linked Immunosorbent Assay (ELISA)
11.3.1.4. Others
11.3.2. Pont Of Care (PoC) Devices
11.3.2.1. Phone Chips (Microfluidics + ICT)
11.3.2.2. Portable/Bench
11.3.2.3. Diagnostics Kits
11.4. Market Attractiveness Analysis By Devices
12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021
12.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1. United States of America
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Disease
13.4.3. By Diagnostic Test
13.4.4. By Devices
13.4.5. By Location Of Diagnostic Test
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Disease
13.5.3. By Diagnostic Test
13.5.4. By Devices
13.5.5. By Location Of Diagnostic Test
14. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Disease
14.4.3. By Diagnostic Test
14.4.4. By Devices
14.4.5. By Location Of Diagnostic Test
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Disease
14.5.3. By Diagnostic Test
14.5.4. By Devices
14.5.5. By Location Of Diagnostic Test
15. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. United Kingdom
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Disease
15.4.3. By Diagnostic Test
15.4.4. By Devices
15.4.5. By Location Of Diagnostic Test
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Disease
15.5.3. By Diagnostic Test
15.5.4. By Devices
15.5.5. By Location Of Diagnostic Test
16. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
16.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Disease
16.4.3. By Diagnostic Test
16.4.4. By Devices
16.4.5. By Location Of Diagnostic Test
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Disease
16.5.3. By Diagnostic Test
16.5.4. By Devices
16.5.5. By Location Of Diagnostic Test
17. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
17.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Disease
17.4.3. By Diagnostic Test
17.4.4. By Devices
17.4.5. By Location Of Diagnostic Test
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Disease
17.5.3. By Diagnostic Test
17.5.4. By Devices
17.5.5. By Location Of Diagnostic Test
18. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.2.2.1. By Disease
18.2.2.2. By Diagnostic Test
18.2.2.3. By Devices
18.2.2.4. By Location Of Diagnostic Test
18.3. Canada Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.3.2.1. By Disease
18.3.2.2. By Diagnostic Test
18.3.2.3. By Devices
18.3.2.4. By Location Of Diagnostic Test
18.4. Mexico Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.4.2.1. By Disease
18.4.2.2. By Diagnostic Test
18.4.2.3. By Devices
18.4.2.4. By Location Of Diagnostic Test
18.5. Brazil Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.5.2.1. By Disease
18.5.2.2. By Diagnostic Test
18.5.2.3. By Devices
18.5.2.4. By Location Of Diagnostic Test
18.6. Germany Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.6.2.1. By Disease
18.6.2.2. By Diagnostic Test
18.6.2.3. By Devices
18.6.2.4. By Location Of Diagnostic Test
18.7. France Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.7.2.1. By Disease
18.7.2.2. By Diagnostic Test
18.7.2.3. By Devices
18.7.2.4. By Location Of Diagnostic Test
18.8. Italy Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.8.2.1. By Disease
18.8.2.2. By Diagnostic Test
18.8.2.3. By Devices
18.8.2.4. By Location Of Diagnostic Test
18.9. BENELUX Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.9.2.1. By Disease
18.9.2.2. By Diagnostic Test
18.9.2.3. By Devices
18.9.2.4. By Location Of Diagnostic Test
18.10. UK Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.10.2.1. By Disease
18.10.2.2. By Diagnostic Test
18.10.2.3. By Devices
18.10.2.4. By Location Of Diagnostic Test
18.11. Nordic Countries Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.11.2.1. By Disease
18.11.2.2. By Diagnostic Test
18.11.2.3. By Devices
18.11.2.4. By Location Of Diagnostic Test
18.12. China Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.12.2.1. By Disease
18.12.2.2. By Diagnostic Test
18.12.2.3. By Devices
18.12.2.4. By Location Of Diagnostic Test
18.13. Japan Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.13.2.1. By Disease
18.13.2.2. By Diagnostic Test
18.13.2.3. By Devices
18.13.2.4. By Location Of Diagnostic Test
18.14. South Korea Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.14.2.1. By Disease
18.14.2.2. By Diagnostic Test
18.14.2.3. By Devices
18.14.2.4. By Location Of Diagnostic Test
18.15. GCC Countries Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.15.2.1. By Disease
18.15.2.2. By Diagnostic Test
18.15.2.3. By Devices
18.15.2.4. By Location Of Diagnostic Test
18.16. South Africa Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.16.2.1. By Disease
18.16.2.2. By Diagnostic Test
18.16.2.3. By Devices
18.16.2.4. By Location Of Diagnostic Test
18.17. Turkey Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.17.2.1. By Disease
18.17.2.2. By Diagnostic Test
18.17.2.3. By Devices
18.17.2.4. By Location Of Diagnostic Test
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional Footprint of Players
19.4.2. Product Footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Abbott Laboratories
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Cephied (Danaher Corporation)
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Diasorin S.p.A
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Hologic Inc
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Siemens AG
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Medmira Inc
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Qiagen INC
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. BioMeriuex
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Bio-Rad Laboratories
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Thermo Fisher Corporation
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
21. Assumptions and Acronyms Used22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million), By Disease, 2015 to 2021
Table 2: Global Market Value (US$ Million), By Disease, 2022 to 2032
Table 3: Global Market Value (US$ Million), By Diagnostic Test, 2015 to 2021
Table 4: Global Market Value (US$ Million), By Diagnostic Test, 2022 to 2032
Table 5: Global Market Value (US$ Million), By Location Of Diagnostic Test, 2015 to 2021
Table 6: Global Market Value (US$ Million), By Location Of Diagnostic Test, 2022 to 2032
Table 7: Global Market Value (US$ Million), By Devices, 2015 to 2021
Table 8: Global Market Value (US$ Million), By Devices, 2022 to 2032
Table 9: Global Market, By Region, 2015 to 2021
Table 10: Global Market, By Region, 2022 to 2032
Table 11: North America Market Value (US$ Million), By Disease, 2015 to 2021
Table 12: North America Market Value (US$ Million), By Disease, 2022 to 2032
Table 13: North America Market Value (US$ Million), By Diagnostic Test, 2015 to 2021
Table 14: North America Market Value (US$ Million), By Diagnostic Test, 2022 to 2032
Table 15: North America Market Value (US$ Million), By Location Of Diagnostic Test, 2015 to 2021
Table 16: North America Market Value (US$ Million), By Location Of Diagnostic Test, 2022 to 2032
Table 17: North America Market Value (US$ Million), By Devices, 2015 to 2021
Table 18: North America Market Value (US$ Million), By Devices, 2022 to 2032
Table 19: North America Market, By Country, 2015 to 2021
Table 20: North America Market, By Country, 2022 to 2032
Table 21: Latin America Market Value (US$ Million), By Disease, 2015 to 2021
Table 22: Latin America Market Value (US$ Million), By Disease, 2022 to 2032
Table 23: Latin America Market Value (US$ Million), By Diagnostic Test, 2015 to 2021
Table 24: Latin America Market Value (US$ Million), By Diagnostic Test, 2022 to 2032
Table 25: Latin America Market Value (US$ Million), By Location Of Diagnostic Test, 2015 to 2021
Table 26: Latin America Market Value (US$ Million), By Location Of Diagnostic Test, 2022 to 2032
Table 27: Latin America Market Value (US$ Million), By Devices, 2015 to 2021
Table 28: Latin America Market Value (US$ Million), By Devices, 2022 to 2032
Table 29: Latin America Market, By Country, 2015 to 2021
Table 30: Latin America Market, By Country, 2022 to 2032
Table 31: Europe Market Value (US$ Million), By Disease, 2015 to 2021
Table 32: Europe Market Value (US$ Million), By Disease, 2022 to 2032
Table 33: Europe Market Value (US$ Million), By Diagnostic Test, 2015 to 2021
Table 34: Europe Market Value (US$ Million), By Diagnostic Test, 2022 to 2032
Table 35: Europe Market Value (US$ Million), By Location Of Diagnostic Test, 2015 to 2021
Table 36: Europe Market Value (US$ Million), By Location Of Diagnostic Test, 2022 to 2032
Table 37: Europe Market Value (US$ Million), By Devices, 2015 to 2021
Table 38: Europe Market Value (US$ Million), By Devices, 2022 to 2032
Table 39: Europe Market, By Country, 2015 to 2021
Table 40: Europe Market, By Country, 2022 to 2032
Table 41: Asia Pacific Market Value (US$ Million), By Disease, 2015 to 2021
Table 42: Asia Pacific Market Value (US$ Million), By Disease, 2022 to 2032
Table 43: Asia Pacific Market Value (US$ Million), By Diagnostic Test, 2015 to 2021
Table 44: Asia Pacific Market Value (US$ Million), By Diagnostic Test, 2022 to 2032
Table 45: Asia Pacific Market Value (US$ Million), By Location Of Diagnostic Test, 2015 to 2021
Table 46: Asia Pacific Market Value (US$ Million), By Location Of Diagnostic Test, 2022 to 2032
Table 47: Asia Pacific Market Value (US$ Million), By Devices, 2015 to 2021
Table 48: Asia Pacific Market Value (US$ Million), By Devices, 2022 to 2032
Table 49: Asia Pacific Market, By Country, 2015 to 2021
Table 50: Asia Pacific Market, By Country, 2022 to 2032
Table 51: MEA Market Value (US$ Million), By Disease, 2015 to 2021
Table 52: MEA Market Value (US$ Million), By Disease, 2022 to 2032
Table 53: MEA Market Value (US$ Million), By Diagnostic Test, 2015 to 2021
Table 54: MEA Market Value (US$ Million), By Diagnostic Test, 2022 to 2032
Table 55: MEA Market Value (US$ Million), By Location Of Diagnostic Test, 2015 to 2021
Table 56: MEA Market Value (US$ Million), By Location Of Diagnostic Test, 2022 to 2032
Table 57: MEA Market Value (US$ Million), By Devices, 2015 to 2021
Table 58: MEA Market Value (US$ Million), By Devices, 2022 to 2032
Table 59: MEA Market, By Country, 2015 to 2021
Table 60: MEA Market, By Country, 2022 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million
Figure 3: Global Market Share, By Disease, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Disease - 2022 to 2032
Figure 5: Global Market Attractiveness Index, By Disease - 2022 to 2032
Figure 6: Global Market Share, By Diagnostic Test, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By Diagnostic Test - 2022 to 2032
Figure 8: Global Market Attractiveness Index, By Diagnostic Test - 2022 to 2032
Figure 9: Global Market Share, By Devices, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Devices - 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Devices - 2022 to 2032
Figure 12: Global Market Share, By Location Of Diagnostic Test, 2022 & 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Location Of Diagnostic Test - 2022 to 2032
Figure 14: Global Market Attractiveness Index, By Location Of Diagnostic Test - 2022 to 2032
Figure 15: Global Market Share, By Region, 2022 & 2032
Figure 16: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032
Figure 17: Global Market Attractiveness Index, By Region - 2022 to 2032
Figure 18: North America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032
Figure 19: North America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 20: North America Market Share, By Disease, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Disease - 2022 to 2032
Figure 22: North America Market Attractiveness Index, By Disease - 2022 to 2032
Figure 23: North America Market Share, By Diagnostic Test, 2022 & 2032
Figure 24: North America Market Y-o-Y Growth Projections, By Diagnostic Test - 2022 to 2032
Figure 25: North America Market Attractiveness Index, By Diagnostic Test - 2022 to 2032
Figure 26: North America Market Share, By Devices, 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Devices - 2022 to 2032
Figure 28: North America Market Attractiveness Index, By Devices - 2022 to 2032
Figure 29: North America Market Share, By Location Of Diagnostic Test, 2022 & 2032
Figure 30: North America Market Y-o-Y Growth Projections, By Location Of Diagnostic Test - 2022 to 2032
Figure 31: North America Market Attractiveness Index, By Location Of Diagnostic Test - 2022 to 2032
Figure 32: North America Market Share, By Country, 2022 & 2032
Figure 33: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 34: North America Market Attractiveness Index, By Country - 2022 to 2032
Figure 35: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032
Figure 36: Latin America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 37: Latin America Market Share, By Disease, 2022 & 2032
Figure 38: Latin America Market Y-o-Y Growth Projections, By Disease - 2022 to 2032
Figure 39: Latin America Market Attractiveness Index, By Disease - 2022 to 2032
Figure 40: Latin America Market Share, By Diagnostic Test, 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Projections, By Diagnostic Test - 2022 to 2032
Figure 42: Latin America Market Attractiveness Index, By Diagnostic Test - 2022 to 2032
Figure 43: Latin America Market Share, By Devices, 2022 & 2032
Figure 44: Latin America Market Y-o-Y Growth Projections, By Devices - 2022 to 2032
Figure 45: Latin America Market Attractiveness Index, By Devices - 2022 to 2032
Figure 46: Latin America Market Share, By Location Of Diagnostic Test, 2022 & 2032
Figure 47: Latin America Market Y-o-Y Growth Projections, By Location Of Diagnostic Test - 2022 to 2032
Figure 48: Latin America Market Attractiveness Index, By Location Of Diagnostic Test - 2022 to 2032
Figure 49: Latin America Market Share, By Country, 2022 & 2032
Figure 50: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 51: Latin America Market Attractiveness Index, By Country - 2022 to 2032
Figure 52: Europe Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032
Figure 53: Europe Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 54: Europe Market Share, By Disease, 2022 & 2032
Figure 55: Europe Market Y-o-Y Growth Projections, By Disease - 2022 to 2032
Figure 56: Europe Market Attractiveness Index, By Disease - 2022 to 2032
Figure 57: Europe Market Share, By Diagnostic Test, 2022 & 2032
Figure 58: Europe Market Y-o-Y Growth Projections, By Diagnostic Test - 2022 to 2032
Figure 59: Europe Market Attractiveness Index, By Diagnostic Test - 2022 to 2032
Figure 60: Europe Market Share, By Devices, 2022 & 2032
Figure 61: Europe Market Y-o-Y Growth Projections, By Devices - 2022 to 2032
Figure 62: Europe Market Attractiveness Index, By Devices - 2022 to 2032
Figure 63: Europe Market Share, By Location Of Diagnostic Test, 2022 & 2032
Figure 64: Europe Market Y-o-Y Growth Projections, By Location Of Diagnostic Test - 2022 to 2032
Figure 65: Europe Market Attractiveness Index, By Location Of Diagnostic Test - 2022 to 2032
Figure 66: Europe Market Share, By Country, 2022 & 2032
Figure 67: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 68: Europe Market Attractiveness Index, By Country - 2022 to 2032
Figure 69: MEA Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032
Figure 70: MEA Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 71: MEA Market Share, By Disease, 2022 & 2032
Figure 72: MEA Market Y-o-Y Growth Projections, By Disease - 2022 to 2032
Figure 73: MEA Market Attractiveness Index, By Disease - 2022 to 2032
Figure 74: MEA Market Share, By Diagnostic Test, 2022 & 2032
Figure 75: MEA Market Y-o-Y Growth Projections, By Diagnostic Test - 2022 to 2032
Figure 76: MEA Market Attractiveness Index, By Diagnostic Test - 2022 to 2032
Figure 77: MEA Market Share, By Devices, 2022 & 2032
Figure 78: MEA Market Y-o-Y Growth Projections, By Devices - 2022 to 2032
Figure 79: MEA Market Attractiveness Index, By Devices - 2022 to 2032
Figure 80: MEA Market Share, By Location Of Diagnostic Test, 2022 & 2032
Figure 81: MEA Market Y-o-Y Growth Projections, By Location Of Diagnostic Test - 2022 to 2032
Figure 82: MEA Market Attractiveness Index, By Location Of Diagnostic Test - 2022 to 2032
Figure 83: MEA Market Share, By Country, 2022 & 2032
Figure 84: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 85: MEA Market Attractiveness Index, By Country - 2022 to 2032
Figure 86: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032
Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million
Figure 88: Asia Pacific Market Share, By Disease, 2022 & 2032
Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Disease - 2022 to 2032
Figure 90: Asia Pacific Market Attractiveness Index, By Disease - 2022 to 2032
Figure 91: Asia Pacific Market Share, By Diagnostic Test, 2022 & 2032
Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Diagnostic Test - 2022 to 2032
Figure 93: Asia Pacific Market Attractiveness Index, By Diagnostic Test - 2022 to 2032
Figure 94: Asia Pacific Market Share, By Devices, 2022 & 2032
Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By Devices - 2022 to 2032
Figure 96: Asia Pacific Market Attractiveness Index, By Devices - 2022 to 2032
Figure 97: Asia Pacific Market Share, By Location Of Diagnostic Test, 2022 & 2032
Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Location Of Diagnostic Test - 2022 to 2032
Figure 99: Asia Pacific Market Attractiveness Index, By Location Of Diagnostic Test - 2022 to 2032
Figure 100: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032
Figure 102: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032
